Skip to main content

Clinical

RSS  

Articles

  • Pharmacology Watch: Apixaban is Heating Up the Anticoagulation Market

    In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
  • Vitamin D: Health and Disease

    A few years ago, vitamin E was deemed to be an extremely important nutrient required to maintain health, prevent or delay several disorders, and prolong life. However, many clinical trials involving intervention with supplemental administration of vitamin E failed to establish or confirm these benefits. A similar prominence is being afforded at present to vitamin D because of relationships being documented between vitamin D deficiency and multiple outcomes, including several disorders and mortality.
  • HPV vaccine rates trail teen vaccines

    Results from a new survey by the Centers for Disease Control and Prevention (CDC) show that teen vaccination rates for human papillomavirus (HPV) remain low in comparison with other vaccines administered to young adults.
  • EPT gets support from ACOG

    If you haven't included expedited partner therapy (EPT) in your practice of treating patients with gonorrhea and chlamydia, more support for the measure has arrived in the form of a new committee opinion from the American College of Obstetricians and Gynecologists.
  • What will it take to boost vasectomy use?

    While vasectomy is a safe, simple, effective form of contraception, female sterilization is the preferred method of sterilization among couples in the United States. About 17% of women between ages 15-44 have had tubal sterilizations, while only 6% rely on male sterilization for birth control.
  • Washington Watch: Medicaid targeted by budget hawks

    At the federal and state levels, cutting government spending has led the political agenda in 2011, and conservative policymakers have specifically targeted Medicaid.
  • More clinicians put US MEC into practice

    Are you implementing guidance from the US Medical Eligibility Criteria for Contraceptive Use, 2010, (US MEC) released by the Centers for Disease Control and Prevention (CDC)?
  • Potential link found between hormonal contraception, HIV risk

    Results from an analysis presented at the recent 2011 International AIDS Society conference in Rome suggest that using certain methods of hormonal contraception particularly injectable contraception might double the risk of HIV acquisition in a previously uninfected woman and also might double the risk that an HIV- infected woman will transmit HIV to a previously uninfected male sexual partner.
  • Heads Up: The Integrative Approach to Migraine Prophylaxis

    Migraine headaches affect 11% of the world's population.1 Since 90% of migraineurs experience moderate to severe pain and 35% are bedridden with headache episodes, the World Health Organization has listed migraine among the top 20 disability-causing diseases.
  • Clinical Briefs in Primary Care supplement